The Apelin/APJ System: A Potential Therapeutic Target for Sepsis
Qing Song,Xi Wang,Zhenhuan Cao,Chun Xin,Jingyuan Zhang,Suwei Li
DOI: https://doi.org/10.2147/jir.s436169
IF: 4.5
2024-01-17
Journal of Inflammation Research
Abstract:Qing Song, Xi Wang, &ast Zhenhuan Cao, &ast Chun Xin, &ast Jingyuan Zhang, &ast Suwei Li Intensive Care Unit, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, 116000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Suwei Li, Tel +86 180 9887 5867, Email Apelin is the native ligand for the G protein-coupled receptor APJ. Numerous studies have demonstrated that the Apelin/APJ system has positive inotropic, anti-inflammatory, and anti-apoptotic effects and regulates fluid homeostasis. The Apelin/APJ system has been demonstrated to play a protective role in sepsis and may serve as a promising therapeutic target for the treatment of sepsis. Better understanding of the mechanisms of the effects of the Apelin/APJ system will aid in the development of novel drugs for the treatment of sepsis. In this review, we provide a brief overview of the physiological role of the Apelin/APJ system and its role in sepsis. Keywords: apelin, sepsis, organ dysfunction, hemodynamics, fluid homeostasis Sepsis is a condition in which the body's response to infection becomes uncontrolled. Sepsis can lead to life-threatening organ dysfunction and is one of the main causes of death for patients in the intensive care unit. 1,2 Fluid resuscitation and vasopressors are the cornerstones for sepsis treatment. The major causes for circulatory failure and failed interventions for septic shock are microvascular leakage, irresponsiveness of arteries to vasopressors and myocardial injury. Despite the implementation of organ support measures like fluid resuscitation, vasoactive drugs, inotropic agents, mechanical ventilation and hemodialysis, the overall prognosis of sepsis has not shown improvement. 3 An effective strategy for the prevention and treatment of sepsis is lacking. Figure 1 There is a wide range of physiological effects caused by the activation of APJ receptors in both the central and peripheral nervous systems. (eg vasodilatory, vasoconstrictive, angiogenic, and possibly antithrombotic; increases myocyte conduction velocity, arrhythmogenic, and decreases myocardial hypertrophy and fibrosis; enhances renal blood flow and diuresis, and reduces fibrosis; inhibits the release of vasopressin from the hypothalamus and reduces water intake). Also, the Apelin/APJ system has a variety of metabolic effects. It increases muscle glucose uptake and usage. It also improves insulin sensitivity. Figure 2 Potential impacts of the apelin/APJ system in human sepsis induced organ disfunction. Both apelin and ELA reduce organs inflammation, improve hemodynamics (eg, improvement of inotropy, reduction of pre- and post-load as well as vascular permeability). Also, apelin reduce the inflammation in the brain, lung, kidney and liver. Furthermore, it prevents pulmonary edema and fibrosis, reduce blood brain barrier permeability, and enhance diuresis. Figure 3 Changes of Apelin in serum of patients with sepsis. ( A ) Changes in serum Apelin in patients with septic myocardial injury. ©2022. Spandidos Publications. Reprinted from Luo Q, Liu G, Chen G, et al. Apelin protects against sepsis‐induced cardiomyopathy by inhibiting the TLR4 and NLRP3 signaling pathways. IntJ Mol Med . 2018;42(2):1161–1167. 43 ( B ) Changes in serum Apelin in septic ARDS patients and the relationship between Apelin levels and prognosis. Copyright ©2022. Dove Medical Press. Reprinted from Yuan Y, Wang W, Zhang Y, et al. Apelin-13 attenuates lipopolysaccharide-induced inflammatory responses and acute lung injury by regulating PFKFB3-driven glycolysis induced by NOX4-dependent ROS. J Inflamm Res . 2022;15:2121–2139. 44 ( C ) Changes in Apelin and ELA in the serum of septic patients, whose stability is reduced in the septic environment. Reprinted from Coquerel D, Lamoureux J, Chagnon F, et al. Apelin-13 in septic shock: effective in supporting hemodynamics in sheep but compromised by enzymatic breakdown in patients. Sci Rep . 2021;11(1):22770. 46 *P<0.05, **P<0.01, ****P<0.0001. Figure 4 The protective effect and mechanism of apelin on cardiac function. ( A ) Apelin increases MAP, CO, cardiac contractility, and improves hemodynamics in sheep with septic shock. Reprinted from Coquerel D, Lamoureux J, Chagnon F, et al. Apelin-13 in septic shock: effective in supporting hemodynamics in sheep but compromised by enzymatic breakdown in patients. Sci Rep. 2021;11(1):22770. 46 ( B ) Apelin attenuates myocardial hydrolysis and neutralizes apoptosis in septic rats. ©2022. Spandidos Publications. Reprinted from -Abstract Truncated-
immunology